perspectivetherapeutics.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CATX

Tandha merek Perspective Tx (CATX)

Expanding the radiopharmaceutical network through clinics and FDA support provides Perspective Therapeutics (CATX) with high patient loyalty. Partnerships with nuclear medicine centers accelerate the implementation of targeted drugs, while unique alpha-radiation patents block competitor entry. EBITDA analytics confirm commercial sustainability, with the latest figure standing at 0.00, illustrating the company's real cash flow.

CATX: Bathi sadurunge mbayar bunga, pajak, lan amortisasi Perspective Therapeutics Inc 23.11.2025 - 10.11.2026

Perspective Therapeutics, Inc. - rincian analitis lan metrik utama (CATX)

- nilai pasar lan prakiraan target analis:
Rega bursa Perspective Tx|CATX - Target konsensus
- rincian nilai pasar emiten:
Nilai pasar Perspective Therapeutics|CATX - Nilai Total Perusahaan
- informasi kapitalisasi buku:
Nilai Buku Saham Perspective Therapeutics|CATX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku perspectivetherapeutics.com|CATX - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Perspective Therapeutics|CATX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Perspective Tx|CATX - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Perspective Therapeutics|CATX - Utang jangka dawa perusahaan|Utang jangka cendhak Perspective Therapeutics|Rasio jangkoan perantara perspectivetherapeutics.com
- informasi bathi lan kelipatan valuasi:
CATX - Bathi resik perusahaan|Bathi mangsa ngarep Perspective Therapeutics|CATX - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Perspective Tx|CATX - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Perspective Therapeutics|CATX - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Perspective Therapeutics|CATX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan perspectivetherapeutics.com|CATX - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Perspective Therapeutics
Ringkesan analitik perusahaan:Perspective Therapeutics, CATX
Produk asli perspectivetherapeutics.com

Perspective Therapeutics creates value through its radiopharmaceutical patent portfolio, though it lacks market pricing power due to regulatory constraints. By analyzing the company's absolute operating profit in cash terms, an investor assesses the daily net cash flow from core operations, which allows for a real-time assessment of the business's financial resilience to external shocks and macroeconomic volatility through the price action on this chart.

Pesaing Perspective Therapeutics (CATX)

Geron Bio (GERN) - Bathi sadurunge bunga, pajak, lan amortisasi|NBTX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BCYC (bicycletherapeutics.com)|CytomX Therapeutics, Inc. (CTMX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi GNLX (Genelux)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Molecular Partners AG|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ONCY|Bathi operasional EBITDA LSTA|Bathi operasional EBITDA moleculin.com (MBRX)|Galera Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MTEM (Molecular Templates Inc)